Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.

While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.